Your browser doesn't support javascript.
loading
The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency.
Styles, Christine T; Paschos, Kostas; White, Robert E; Farrell, Paul J.
Afiliação
  • Styles CT; Molecular Virology, Department of Medicine, Imperial College London, London W2 1PG, UK. christine.styles10@imperial.ac.uk.
  • Paschos K; Molecular Virology, Department of Medicine, Imperial College London, London W2 1PG, UK. k.paschos@imperial.ac.uk.
  • White RE; Molecular Virology, Department of Medicine, Imperial College London, London W2 1PG, UK. robert.e.white@imperial.ac.uk.
  • Farrell PJ; Molecular Virology, Department of Medicine, Imperial College London, London W2 1PG, UK. p.farrell@imperial.ac.uk.
Pathogens ; 7(1)2018 Mar 17.
Article em En | MEDLINE | ID: mdl-29562595
The Epstein-Barr nuclear antigen 3 (EBNA3) family of proteins, comprising EBNA3A, EBNA3B, and EBNA3C, play pivotal roles in the asymptomatic persistence and life-long latency of Epstein-Barr virus (EBV) in the worldwide human population. EBNA3-mediated transcriptional reprogramming of numerous host cell genes promotes in vitro B cell transformation and EBV persistence in vivo. Despite structural and sequence similarities, and evidence of substantial cooperative activity between the EBNA3 proteins, they perform quite different, often opposing functions. Both EBNA3A and EBNA3C are involved in the repression of important tumour suppressive pathways and are considered oncogenic. In contrast, EBNA3B exhibits tumour suppressive functions. This review focuses on how the EBNA3 proteins achieve the delicate balance required to support EBV persistence and latency, with emphasis on the contribution of the Allday laboratory to the field of EBNA3 biology.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Pathogens Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Pathogens Ano de publicação: 2018 Tipo de documento: Article